Eligible Registrants – AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5
Therapeutic modulation of E3 ubiquitin ligase activity
Benjamin L. Ebert
Dana-Farber Cancer Institute, Boston, MA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 26, 2019 5:00 PM-7:00 PM
Successes and failures of targeted drug development in adult and pediatric sarcomas
Jaap Verweij
Erasmus University Medical Center, Rotterdam, Netherlands
from 2019 Molecular Targets and Cancer Therapeutics conference on October 26, 2019 3:00 PM-4:45 PM
Successes and failures of targeted drug development in pediatric tumors
Elizabeth Fox
Children’s Hospital of Pennsylvania, Philadelphia, PA, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 26, 2019 3:00 PM-4:45 PM
Targeted therapy with protein kinase inhibitors: Lessons learned from the last 20 years
Michael C Heinrich
Oregon Health and Science University, Portland, OR, United States
from 2019 Molecular Targets and Cancer Therapeutics conference on October 26, 2019 3:00 PM-4:45 PM
Dissecting antitumor immune response in ovarian cancer
George Coukos
University of Lausanne, Lausanne, Switzerland, Lausanne, Switzerland
from 2019 Molecular Targets and Cancer Therapeutics conference on October 26, 2019 5:00 PM-7:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 5 of 5